)
Edge14 Aug 2026
Deutsche Qualität: The Story of Birkenstock
From an 18th-century German shoemaker to a global footwear brand, how Birkenstock turned an orthopedic insole into the world's most popular sandal.
Livzon Pharmaceutical
Livzon Pharmaceutical (000513) investor relations material
Livzon Pharmaceutical Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary21 Aug, 2026
Executive summary
Revenue for H1 2026 was RMB 4.9997 billion, down 20.28% year-over-year; net profit attributable to shareholders was RMB 932 million, down 27.23%.
Gross margin declined to 61.28%, a decrease of 4.74 percentage points year-over-year.
Operating cash flow remained robust at RMB 1.76 billion, up 4.5% year-over-year.
The company completed the acquisition of a 67.87% stake in Vietnam's Imexpharm Corporation, expanding its international footprint.
Financial highlights
Revenue: RMB 4.9997 billion, -20.28% year-over-year.
Net profit attributable to shareholders: RMB 932 million, -27.23% year-over-year.
EPS: RMB 1.05, -26.57% year-over-year.
Gross margin: 61.28%, down 4.74 percentage points.
Operating cash flow: RMB 1.76 billion, +4.5% year-over-year.
R&D investment: RMB 381.5 million, 7.63% of revenue.
Outlook and guidance
The company expects pricing pressure from national procurement and medical insurance negotiations to persist, impacting mature product margins.
Focus remains on accelerating commercialization of new products and optimizing revenue structure toward innovation-driven growth.
International expansion and digital transformation are strategic priorities.
Drivers for chemical preparation revenue decline
Strategic rationale for the IMP acquisition
Quantifiable efficiency gains from AI in R&D
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Livzon Pharmaceutical
- Q1 2026 saw lower revenue and profit but stronger cash flow and ongoing innovation momentum.000513
Q1 2026 - 2025 revenue up 1.76%, adjusted net profit up 1.51%, and overseas sales rose 11.97%.000513Q4 2025
- Q3 2025 saw modest revenue growth, a dip in net profit, and robust operating cash flow.000513Q3 2025
- Net profit rose 9.40% to RMB 1.28 billion on stable revenue and strong overseas growth.000513Q2 2025
- Net profit rose 4.44% year-over-year to RMB 1.67 billion, despite a 5.94% revenue drop.000513Q3 2024
- Net profit grew 3.21% to RMB 1.17 billion despite a 6.09% revenue decline.000513Q2 2024
- Net profit up 4.75% year-over-year, revenue down 1.92%, with major share buybacks.000513Q1 2025
- Net profit grew 5.5% to RMB 2.06B despite a 4.97% revenue drop, with higher dividend proposed.000513Q4 2024
Next Livzon Pharmaceutical earnings date
Q3 202623 Oct, 2026
Livzon Pharmaceutical
Next Livzon Pharmaceutical earnings date
Q3 202623 Oct, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage